Innovation requires diversity of thought, dynamic conversation, adequate planning, and synergistic collaboration. Those qualities are must-haves for companies internally, but they are also essential when creating external partnerships.
Continuous manufacturing offers productivity and cost-saving benefits among other things, but technical and regulatory challenges have slowed uptake. Speeding up adoption will require innovation and knowledge sharing within the industry and regulatory support from the FDA.
Learn how swallowability and palatability play key factors related to patient acceptability and product development and about the variety of taste masking strategies including excipients, organoleptic and barrier coating approaches, and microencapsulation technologies.
Cell therapy has emerged as one of the most promising disruptive innovations in the pharma industry, but companies developing cell therapies have not been able to take full advantage of its massive potential.
Companies wanting to accelerate biomanufacturing operations and use resources efficiently need access to technologies and solutions that can safely and efficiently complete workflow from idea to injection.